中国临床药理学杂志
中國臨床藥理學雜誌
중국림상약이학잡지
THE CHINESE JOURNAL OF CLINICAL PHARMACOLOGY
2014年
4期
350-353
,共4页
青霉素%头孢菌素%阿莫西林%幽门螺杆菌
青黴素%頭孢菌素%阿莫西林%幽門螺桿菌
청매소%두포균소%아막서림%유문라간균
penecillin%cephalosporin%amoxicillin%H.pylori
目的:系统评价基于头孢菌素类或青霉素类幽门螺杆菌根除方案的有效性及安全性。方法计算机检索Pubmed、Embase等数据库,收集相关随机对照试验,终点指标为幽门螺杆菌根除率、不良反应发生率以及溃疡愈合率。共纳入5项研究,513名患者。结果基于头孢菌素类或青霉素类根除方案的有效性,两者差别无统计学意义( P>0.05)。药物不良反应发生率,头孢菌素组显著低于青霉素组( P<0.01);无严重不良反应发生。结论2种方案有效性相似,但头孢菌素类较青霉素类不良反应发生率更低。
目的:繫統評價基于頭孢菌素類或青黴素類幽門螺桿菌根除方案的有效性及安全性。方法計算機檢索Pubmed、Embase等數據庫,收集相關隨機對照試驗,終點指標為幽門螺桿菌根除率、不良反應髮生率以及潰瘍愈閤率。共納入5項研究,513名患者。結果基于頭孢菌素類或青黴素類根除方案的有效性,兩者差彆無統計學意義( P>0.05)。藥物不良反應髮生率,頭孢菌素組顯著低于青黴素組( P<0.01);無嚴重不良反應髮生。結論2種方案有效性相似,但頭孢菌素類較青黴素類不良反應髮生率更低。
목적:계통평개기우두포균소류혹청매소류유문라간균근제방안적유효성급안전성。방법계산궤검색Pubmed、Embase등수거고,수집상관수궤대조시험,종점지표위유문라간균근제솔、불량반응발생솔이급궤양유합솔。공납입5항연구,513명환자。결과기우두포균소류혹청매소류근제방안적유효성,량자차별무통계학의의( P>0.05)。약물불량반응발생솔,두포균소조현저저우청매소조( P<0.01);무엄중불량반응발생。결론2충방안유효성상사,단두포균소류교청매소류불량반응발생솔경저。
Objective To compare the relative efficacy and safety of cephalosporins or penicillins based H.pylori eradication regimen.Meth-ods Electronic databases were searched to identify the randomized con-trolled trials ( RCTs ) comparing cephalosporins and penecillins for H.pylori eradication.The outcome measure was H.pylori eradication rate , incidence of adverse drug reactions ( ADR) and ulcer healing.Five stud-ies including 513 patients were identified.Results No statistical differ-ence on H.pylori eradication efficacy between cephalosporins and peni-cillins based regimen was shown on Meta -analysis ( P>0.05 ).No se-vere adverse drug reaction ( ADR) was reported in the identified studies , but the incidence of ADR of cephalosporins group was significantly lower than that of penicillin group ( P<0.01 ).Conclusion The efficacy of cephalosporins is similar to penicillins for H.pylori eradication , but cephalosporins have shown a significantly lower incidence of ADR.